
Results
44
Stocks where the price continues to rise after more than a year of consistent gains.
44 companies
Moderna
Market Cap: US$25.1b
A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
MRNA
US$174.38
7D
173.9%
1Y
548.5%
BioNTech
Market Cap: US$23.3b
Engages in the development and commercialization of immunotherapies in Germany.
BNTX
US$113.12
7D
22.0%
1Y
1.6%
Amylyx Pharmaceuticals
Market Cap: US$3.9b
A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.
AMLX
US$38.60
7D
65.3%
1Y
380.7%
Eton Pharmaceuticals
Market Cap: US$1.8b
A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
ETON
US$61.48
7D
47.9%
1Y
271.5%
Maravai LifeSciences Holdings
Market Cap: US$1.5b
A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.
MRVI
US$7.22
7D
24.9%
1Y
193.5%
Omeros
Market Cap: US$1.3b
A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.
OMER
US$17.19
7D
26.4%
1Y
294.3%
Kura Oncology
Market Cap: US$1.1b
A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.
KURA
US$12.53
7D
26.1%
1Y
77.7%
Climb Bio
Market Cap: US$998.8m
A clinical-stage biotechnology company, focuses on developing therapies to address unmet needs for patients living with immune-mediated diseases.
CLYM
US$17.34
7D
20.5%
1Y
670.7%
Candel Therapeutics
Market Cap: US$922.0m
A clinical stage biopharmaceutical company, develops immunotherapies for cancer patients.
CADL
US$13.50
7D
26.4%
1Y
142.8%
Hubei Biocause Heilen Pharmaceutical
Market Cap: CN¥6.1b
Hubei Biocause Heilen Pharmaceutical Co., Ltd.
301211
CN¥14.54
7D
24.2%
1Y
12.4%
Boji Medical TechnologyLtd
Market Cap: CN¥5.9b
Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.
300404
CN¥15.35
7D
27.5%
1Y
24.2%
4D Molecular Therapeutics
Market Cap: US$813.2m
A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.
FDMT
US$16.76
7D
41.2%
1Y
144.7%
Achieve Life Sciences
Market Cap: US$773.8m
A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.
ACHV
US$8.53
7D
27.5%
1Y
230.6%
Assembly Biosciences
Market Cap: US$654.2m
A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.
ASMB
US$33.84
7D
25.1%
1Y
29.4%
Shanghai Shenqi Pharmaceutical Investment Management
Market Cap: CN¥3.9b
Operates as a pharmaceutical manufacturing holding investment company in China.
600613
CN¥7.78
7D
46.8%
1Y
9.6%
OmniAb
Market Cap: US$569.9m
A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.
OABI
US$4.19
7D
22.5%
1Y
129.0%
Xinjiang Tianshan Animal Husbandry Bio-engineering
Market Cap: CN¥3.5b
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.
300313
CN¥14.45
7D
70.4%
1Y
59.0%
Morepen Laboratories
Market Cap: ₹48.5b
Develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally.
500288
₹88.43
7D
20.2%
1Y
77.8%
Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd
Market Cap: CN¥2.5b
Engages in the research, development, production, and sales of chemical raw materials and pharmaceutical preparations in China.
301130
CN¥33.38
7D
31.4%
1Y
0.7%
AVITA Medical
Market Cap: US$304.6m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$10.34
7D
27.3%
1Y
120.5%
Cardiol Therapeutics
Market Cap: CA$304.9m
A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$2.70
7D
27.4%
1Y
68.8%
Acumen Pharmaceuticals
Market Cap: US$198.1m
A clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer’s disease.
ABOS
US$3.15
7D
25.5%
1Y
123.4%
Nykode Therapeutics
Market Cap: NOK 1.6b
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.
NYKD
NOK 4.93
7D
45.9%
1Y
177.0%
Apollomics
Market Cap: US$52.5m
A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.
APLM
US$23.59
7D
38.3%
1Y
328.9%
Valiant Laboratories
Market Cap: ₹5.0b
Operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally.
VALIANTLAB
₹91.96
7D
23.0%
1Y
4.4%
Bilcare
Market Cap: ₹2.3b
Provides pharmaceutical packaging research solutions in India and internationally.
526853
₹91.75
7D
41.2%
1Y
36.5%
NextCell Pharma
Market Cap: SEK 163.0m
A biopharmaceutical company, engages in the research, development, and manufacture of stromal cell therapies in Sweden.
NXTCL
SEK 1.29
7D
28.7%
1Y
9.7%
Brainstorm Cell Therapeutics
Market Cap: US$15.6m
A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.
BCLI
US$1.22
7D
40.3%
1Y
96.4%
Pharmala Biotech Holdings
Market Cap: CA$20.2m
A biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.
MDMA
CA$0.21
7D
26.5%
1Y
72.0%
Aton
Market Cap: €12.4m
Operates as a bioscience company in France.
ALTAO
€0.015
7D
31.6%
1Y
82.9%
Dannex Ayrton Starwin
Market Cap: GH₵75.4m
Engages in the manufacturing, importing, and sale of pharmaceutical products in Ghana.
DASPHARMA
GH₵0.97
7D
56.5%
1Y
155.3%
Nuformix
Market Cap: UK£4.8m
Together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom.
NFX
UK£0.0019
7D
43.4%
1Y
124.2%
International Stem Cell
Market Cap: US$3.9m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.51
7D
57.0%
1Y
216.1%
1933 Industries
Market Cap: CA$5.2m
Engages in the cultivation, extraction, and production of cannabis products in the United States.
TGIF
CA$0.01
7D
100.0%
1Y
0%
Enzolytics
Market Cap: US$3.4m
A drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.
ENZC
US$0.0007
7D
27.3%
1Y
16.7%
Zenith Capital
Market Cap: US$3.2m
A biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs.
ZHCL.F
US$0.10
7D
100.0%
1Y
100.0%